Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant

被引：7

作者：

Li, Gen ^{[1
]}

Zhou, Zhongcheng ^{[1
]}

Du, Peng ^{[1
]}

Zhan, Meixiao ^{[2
]}

Li, Ning ^{[1
]}

Xiong, Xinxin ^{[1
]}

Tang, Shengjun ^{[1
]}

Man, Miao ^{[2
,3
,4
,5
,6
]}

Baptista-Hon, Daniel T. ^{[2
,3
,4
,5
,6
]}

Lu, Ligong ^{[2
]}

机构：

[1] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou, Peoples R China

[2] Macau Univ Technol, Zhuhai Peoples Hosp, Affiliated Hosp 1, Zhuhai Precis Med Ctr,Fac Med, Zhuhai, Guangdong, Peoples R China

[3] Guangzhou Lab, Dept Bioinformat & AI, Guangzhou, Peoples R China

[4] Macau Univ Sci & Technol, Univ Hosp, Taipa 999078, Macao, Peoples R China

[5] Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Taipa 999078, Macao, Peoples R China

[6] Macau Univ Sci & Technol, Fac Med, Taipa 999078, Macao, Peoples R China

来源：

SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2022年 / 7卷 / 01期

关键词：

D O I：

10.1038/s41392-022-01062-3

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：3

共 10 条

[1] Homologous and Heterologous Covid-19 Booster Vaccinations
Atmar, R. L.
Lyke, K. E.
Deming, M. E.
Jackson, L. A.
Branche, A. R.
El Sahly, H. M.
Rostad, C. A.
Martin, J. M.
Johnston, C.
Rupp, R. E.
Mulligan, M. J.
Brady, R. C.
Frenck, R. W., Jr.
Backer, M.
Kottkamp, A. C.
Babu, T. M.
Rajakumar, K.
Edupuganti, S.
Dobrzynski, D.
Coler, R. N.
Posavad, C. M.
Archer, J., I
Crandon, S.
Nayak, S. U.
Szydlo, D.
Zemanek, J. A.
Islas, C. P. Dominguez
Brown, E. R.
Suthar, M. S.
McElrath, M. J.
McDermott, A. B.
Montefiori, D. C.
Eaton, A.
Neuzil, K. M.
Stephens, D. S.
Roberts, P. C.
Beigel, J. H.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (11) : 1046 - 1057
[2] Cao Y., BIORXIV, DOI [10.1101/2022.02.07.479349(2022, DOI 10.1101/2022.02.07.479349(2022]
[3] Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
Cheng, Samuel M. S.
Mok, Chris Ka Pun
Leung, Yonna W. Y.
Ng, Susanna S.
Chan, Karl C. K.
Ko, Fanny W.
Chen, Chunke
Yiu, Karen
Lam, Bosco H. S.
Lau, Eric H. Y.
Chan, Ken K. P.
Luk, Leo L. H.
Li, John K. C.
Tsang, Leo C. H.
Poon, Leo L. M.
Hui, David S. C.
Peiris, Malik
[J]. NATURE MEDICINE, 2022, 28 (03) : 486 - +
[4] Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults
Dai, Lianpan
Gao, Lidong
Tao, Lifeng
Hadinegoro, Sri R.
Erkin, Musabaev
Ying, Zhifang
He, Peng
Girsang, Rodman T.
Vergara, Hugo
Akram, Javed
Satari, Hindra, I
Khaliq, Tanwir
Sughra, Ume
Celi, Ana P.
Li, Fangjun
Li, Yan
Jiang, Zhiwei
Dalimova, Dilbar
Tuychiev, Jaloliddin
Turdikulova, Shahlo
Ikram, Aamer
Flores Lastra, Nancy
Ding, Fan
Suhardono, Mahendra
Fadlyana, Eddy
Yan, Jinghua
Hu, Zhongyu
Li, Changgui
Abdurakhmonov, Ibrokhim Y.
Gao, George F.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (22) : 2097 - 2111
[5] Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
Jara, Alejandro
Undurraga, Eduardo A.
Zubizarreta, Jose R.
Gonzalez, Cecilia
Pizarro, Alejandra
Acevedo, Johanna
Leo, Katherinne
Paredes, Fabio
Bralic, Tomas
Vergara, Veronica
Mosso, Marcelo
Leon, Francisco
Parot, Ignacio
Leighton, Paulina
Suarez, Pamela
Carlos Rios, Juan
Garcia-Escorza, Heriberto
Araos, Rafael
[J]. LANCET GLOBAL HEALTH, 2022, 10 (06): : E798 - E806
[6] Lyngse F. P., PREPRINT, DOI DOI 10.1101/2022.01.28.22270044(2022
[7] Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Meng, Bo
Abdullahi, Adam
Ferreira, Isabella A. T. M.
Goonawardane, Niluka
Saito, Akatsuki
Kimura, Izumi
Yamasoba, Daichi
Gerber, Pehuen Pereyra
Fatihi, Saman
Rathore, Surabhi
Zepeda, Samantha K.
Papa, Guido
Kemp, Steven A.
Ikeda, Terumasa
Toyoda, Mako
Tan, Toong Seng
Kuramochi, Jin
Mitsunaga, Shigeki
Ueno, Takamasa
Shirakawa, Kotaro
Takaori-Kondo, Akifumi
Brevini, Teresa
Mallery, Donna L.
Charles, Oscar J.
Bowen, John E.
Joshi, Anshu
Walls, Alexandra C.
Jackson, Laurelle
Martin, Darren
Smith, Kenneth G. C.
Bradley, John
Briggs, John A. G.
Choi, Jinwook
Madissoon, Elo
Meyer, Kerstin B.
Mlcochova, Petra
Ceron-Gutierrez, Lourdes
Doffinger, Rainer
Teichmann, Sarah A.
Fisher, Andrew J.
Pizzuto, Matteo S.
de Marco, Anna
Corti, Davide
Hosmillo, Myra
Lee, Joo Hyeon
James, Leo C.
Thukral, Lipi
Veesler, David
Sigal, Alex
Sampaziotis, Fotios
[J]. NATURE, 2022, 603 (7902) : 706 - +
[8] A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Yang, Jingyun
Wang, Wei
Chen, Zimin
Lu, Shuaiyao
Yang, Fanli
Bi, Zhenfei
Bao, Linlin
Mo, Fei
Li, Xue
Huang, Yong
Hong, Weiqi
Yang, Yun
Zhao, Yuan
Ye, Fei
Lin, Sheng
Deng, Wei
Chen, Hua
Lei, Hong
Zhang, Ziqi
Luo, Min
Gao, Hong
Zheng, Yue
Gong, Yanqiu
Jiang, Xiaohua
Xu, Yanfeng
Lv, Qi
Li, Dan
Wang, Manni
Li, Fengdi
Wang, Shunyi
Wang, Guanpeng
Yu, Pin
Qu, Yajin
Yang, Li
Deng, Hongxin
Tong, Aiping
Li, Jiong
Wang, Zhenling
Yang, Jinliang
Shen, Guobo
Zhao, Zhiwei
Li, Yuhua
Luo, Jingwen
Liu, Hongqi
Yu, Wenhai
Yang, Mengli
Xu, Jingwen
Wang, Junbin
Li, Haiyan
Wang, Haixuan
[J]. NATURE, 2020, 586 (7830) : 572 - +
[9] Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
Yu, Jingyou
Collier, Ai-ris Y.
Rowe, Marjorie
Mardas, Fatima
Ventura, John D.
Wan, Huahua
Miller, Jessica
Powers, Olivia
Chung, Benjamin
Siamatu, Mazuba
Hachmann, Nicole P.
Surve, Nehalee
Nampanya, Felix
Chandrashekar, Abishek
Barouch, Dan H.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (16)
[10] Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C
Zhou, Zhongcheng
Du, Peng
Yu, Meixing
Baptista-Hon, Daniel T.
Miao, Man
Xiang, Andy P.
Lau, Johnson Yiu-Nam
Li, Gen
Zhang, Kang
[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)

← 1 →